Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MFSD2A: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Gene Symbol | MFSD2A |
| Full Name | Major Facilitator Superfamily Domain Containing 2A |
| Aliases | Page for MFSD2A |
| Chromosome | 1p34.2 |
| Protein Type | Transporter |
| Function | encodes a sodium-dependent lysophosphatidylcholine (LPC) transporter that is essential for blood-brain barrier integrity and brain lipid composition. |
| Amino Acids | 530 aa |
| Exons | 14 |
| Pathways | Blood-Brain Barrier |
| Ensembl ID | ENSG00000168389 |
| GeneCards | MFSD2A |
| Human Protein Atlas | MFSD2A |
| Associated Diseases | neurodegeneration |
| Interactions | PDGFRB, CANCER, NF-ΚB, NEUROINFLAMMATION, PROINFLAMMATORY CYTOKINES, CAVEOLIN-1 |
| KG Connections | 54 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
MFSD2A["<b>MFSD2A</b>"]
Ischemia{"Ischemia"}
MFSD2A -->|"regulates"| Ischemia
Stroke{"Stroke"}
MFSD2A -->|"activates"| Stroke
Ms{"Ms"}
MFSD2A -->|"activates"| Ms
Blood_Brain_Barrier(["Blood-Brain Barrier"])
MFSD2A -->|"regulates"| Blood_Brain_Barrier
neurodegeneration["neurodegeneration"]
MFSD2A -->|"implicated in"| neurodegeneration
TAZ["TAZ"]
TAZ -->|"regulates"| MFSD2A
style MFSD2A fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| PDGFRB | inhibits | gene | 0.65 |
| Ischemia | regulates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Colorectal Cancer | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Gastric Cancer | inhibits | disease | 0.65 |
| Sepsis | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| OLIGODENDROCYTE | causes | cell_type | 0.65 |
| BLOOD-BRAIN BARRIER DISRUPTION | inhibits | phenotype | 0.65 |
| HYPOTHALAMUS | activates | brain_region | 0.65 |
| STROKE | targets | disease | 0.65 |
| STROKE | biomarker_for | disease | 0.65 |
| NEURON | interacts_with | cell_type | 0.65 |
| Blood-Brain Barrier | regulates | pathway | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| Metastasis | inhibits | pathway | 0.60 |
| Invasion | inhibits | pathway | 0.60 |
| Angiogenesis | inhibits | pathway | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| PROINFLAMMATORY CYTOKINES | activates | gene | 0.60 |
| Wnt | inhibits | pathway | 0.60 |
| Blood-Brain Barrier | activates | pathway | 0.60 |
| Nf-Κb | activates | pathway | 0.60 |
| AND | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| Albumin | expressed_in | protein | 0.60 |
| OLIGODENDROCYTE | expressed_in | cell_type | 0.55 |
| CAVEOLIN-1 | activates | protein | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-f5d32997 | targets_gene | hypothesis | 0.90 |
| ENDOTHELIAL CELLS | regulates | cell_type | 0.65 |
| NEURONS | produces | cell_type | 0.65 |
| TAZ | regulates | gene | 0.60 |
| STAT3 | inhibits | gene | 0.60 |
| WNT7A | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| WNT | inhibits | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| CEREBELLUM | associated_with | brain_region | 0.45 |
| HYPOTHALAMUS | associated_with | brain_region | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN | 0.552 | neuropharmacology | What determines blood-brain barrier pene |
| SIRT1-Mediated Epigenetic Restoration of MFSD2A Expression R | 0.498 | neuropharmacology | What determines blood-brain barrier pene |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||